Cytokines and related molecules, and adverse reactions related to platelet concentrate transfusions (Q92055790)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31327557%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

title

Cytokines and related molecules, and adverse reactions related to platelet concentrate transfusions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31327557%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

F Cognasse

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31327557%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

O Garraud

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31327557%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

publication date

4 July 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31327557%20AND%20SRC:MED&resulttype=core&format=json

Transfusion Clinique et Biologique

26 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31327557%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31327557%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31327557%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

page(s)

144-146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31327557%20AND%20SRC:MED&resulttype=core&format=json

Platelet JNK1 is involved in secretion and thrombus formation

26 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Platelet secretion defect in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL-5)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Pathogen sensing, subsequent signalling, and signalosome in human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Platelet Toll-like receptor expression: the link between "danger" ligands and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

A computerized prediction model of hazardous inflammatory platelet transfusion outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Transfusion as an Inflammation Hit: Knowns and Unknowns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

How can non-nucleated platelets be so smart?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Are Platelets Cells? And if Yes, are They Immune Cells?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

The platelet storage lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Microparticle and mitochondrial release during extended storage of different types of platelet concentrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Specific activation, signalling and secretion profiles of human platelets following PAR-1 and PAR-4 stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Amotosalen-HCl-UVA pathogen reduction does not alter poststorage metabolism of soluble CD40 ligand, Ox40 ligand and interkeukin-27, the cytokines that generally associate with serious adverse events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Immune-reactive soluble OX40 ligand, soluble CD40 ligand, and interleukin-27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Removal of biologic response modifiers associated with platelet transfusion reactions: strategies worth considering?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Donor platelets stored for at least 3 days can elicit activation marker expression by the recipient's blood mononuclear cells: an in vitro study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Platelet components associated with acute transfusion reactions: the role of platelet-derived soluble CD40 ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Release of potential immunomodulatory factors during platelet storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Scratching the surface of allergic transfusion reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

How to mitigate the risk of inducing transfusion-associated adverse reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Human platelets and their capacity of binding viruses: meaning and challenges?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

The role of microparticles in inflammation and transfusion: A concise review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

An overview of the role of microparticles/microvesicles in blood components: Are they clinically beneficial or harmful?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Independent evaluation of tolerance of therapeutic plasma inactivated by amotosalen-HCl-UVA (Intercept ™) over a 5-year period of extensive delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Are polymorphisms of the immunoregulatory factor CD40LG implicated in acute transfusion reactions?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

Platelet soluble CD40-ligand level is associated with transfusion adverse reactions in a mixed threshold-and-hit model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

The Non-Hemostatic Aspects of Transfused Platelets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2019.06.324

10.1016/J.TRACLI.2019.06.324

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31327557%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31327557%20AND%20SRC:MED&resulttype=core&format=json